Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Checkpoint Therapeutics, Inc. (CKPT) had Return on Tangible Equity of -68.81% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-11.21M |
|
-- |
|
-- |
|
$11.15M |
|
$-11.15M |
|
$-0.06M |
|
$-11.21M |
|
$-11.21M |
|
$-11.21M |
|
$-11.21M |
|
$-11.21M |
|
$-11.21M |
|
$-11.15M |
|
$-11.15M |
|
59.82M |
|
59.82M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$34.16M |
|
-- |
|
-- |
|
$34.16M |
|
$17.87M |
|
-- |
|
-- |
|
$17.87M |
|
$16.30M |
|
$16.30M |
|
$16.30M |
|
83.76M |
|
| Cash Flow Statement Financials | |
$-11.69M |
|
-- |
|
$38.12M |
|
$6.60M |
|
$33.04M |
|
$26.44M |
|
$1.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.91 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-68.81% |
|
|
Return on Tangible Equity |
-68.81% |
-32.82% |
|
-68.81% |
|
$0.19 |
|
$-0.20 |
|
$-0.20 |
|